225 related articles for article (PubMed ID: 1656243)
1. Estradiol down-regulates the mannose-6-phosphate/insulin-like growth factor-II receptor gene and induces cathepsin-D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes.
Mathieu M; Vignon F; Capony F; Rochefort H
Mol Endocrinol; 1991 Jun; 5(6):815-22. PubMed ID: 1656243
[TBL] [Abstract][Full Text] [Related]
2. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of the mannose 6-phosphate/ insulin-like growth factor-II receptor in human breast cancer cell lines of different invasive potential.
Xie S; Kang JX
Med Sci Monit; 2002 Aug; 8(8):BR293-300. PubMed ID: 12165733
[TBL] [Abstract][Full Text] [Related]
4. Mannose-6-phosphate enhances cross-linking efficiency between insulin-like growth factor-II (IGF-II) and IGF-II/mannose-6-phosphate receptors in membranes.
MacDonald RG
Endocrinology; 1991 Jan; 128(1):413-21. PubMed ID: 1846107
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor II modulates the routing of cathepsin D in MCF-7 breast cancer cells.
De Leon DD; Terry C; Asmerom Y; Nissley P
Endocrinology; 1996 May; 137(5):1851-9. PubMed ID: 8612524
[TBL] [Abstract][Full Text] [Related]
6. The chick embryo fibroblast cation-independent mannose 6-phosphate receptor is functional and immunologically related to the mammalian insulin-like growth factor-II (IGF-II)/man 6-P receptor but does not bind IGF-II.
Yang YW; Robbins AR; Nissley SP; Rechler MM
Endocrinology; 1991 Feb; 128(2):1177-89. PubMed ID: 1846580
[TBL] [Abstract][Full Text] [Related]
7. Liver regeneration is associated with increased expression of the insulin-like growth factor-II/mannose-6-phosphate receptor.
Burguera B; Werner H; Sklar M; Shen-Orr Z; Stannard B; Roberts CT; Nissley SP; Vore SJ; Caro JF; LeRoith D
Mol Endocrinol; 1990 Oct; 4(10):1539-45. PubMed ID: 2178219
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor receptor expression and function in human breast cancer.
Cullen KJ; Yee D; Sly WS; Perdue J; Hampton B; Lippman ME; Rosen N
Cancer Res; 1990 Jan; 50(1):48-53. PubMed ID: 2152773
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors (IGFs) stimulate the release of alpha 1-antichymotrypsin and soluble IGF-II/mannose 6-phosphate receptor from MCF7 breast cancer cells.
Confort C; Rochefort H; Vignon F
Endocrinology; 1995 Sep; 136(9):3759-66. PubMed ID: 7649082
[TBL] [Abstract][Full Text] [Related]
11. Progestins induce down-regulation of insulin-like growth factor-I (IGF-I) receptors in human breast cancer cells: potential autocrine role of IGF-II.
Papa V; Hartmann KK; Rosenthal SM; Maddux BA; Siiteri PK; Goldfine ID
Mol Endocrinol; 1991 May; 5(5):709-17. PubMed ID: 1649393
[TBL] [Abstract][Full Text] [Related]
12. Human and hamster procathepsin D, although equally tagged with mannose-6-phosphate, are differentially targeted to lysosomes in transfected BHK cells.
Isidoro C; Baccino FM; Hasilik A
Cell Tissue Res; 1998 May; 292(2):303-10. PubMed ID: 9560473
[TBL] [Abstract][Full Text] [Related]
13. The two mannose 6-phosphate binding sites of the insulin-like growth factor-II/mannose 6-phosphate receptor display different ligand binding properties.
Marron-Terada PG; Brzycki-Wessell MA; Dahms NM
J Biol Chem; 1998 Aug; 273(35):22358-66. PubMed ID: 9712856
[TBL] [Abstract][Full Text] [Related]
14. Enhanced activity of lysosomal proteases in activated rat hepatic stellate cells is associated with a concomitant increase in the number of the mannose-6-phosphate/insulin-like growth factor II receptor.
Mousavi SA; Fønhus MS; Kindberg GM; Tolleshaug H; Berg T
Cell Biol Int; 2013 Jul; 37(7):703-12. PubMed ID: 23495048
[TBL] [Abstract][Full Text] [Related]
15. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
16. Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells.
Stewart AJ; Johnson MD; May FE; Westley BR
J Biol Chem; 1990 Dec; 265(34):21172-8. PubMed ID: 2174437
[TBL] [Abstract][Full Text] [Related]
17. Decreased secretion of Cathepsin D in breast cancer in vivo by tamoxifen: mediated by the mannose-6-phosphate/IGF-II receptor?
Dabrosin C; Johansson AC; Ollinger K
Breast Cancer Res Treat; 2004 Jun; 85(3):229-38. PubMed ID: 15111761
[TBL] [Abstract][Full Text] [Related]
18. Interactions of pro-cathepsin D and IGF-II on the mannose-6-phosphate/IGF-II receptor.
Vignon F; Rochefort H
Breast Cancer Res Treat; 1992; 22(1):47-57. PubMed ID: 1421424
[TBL] [Abstract][Full Text] [Related]
19. Expression of the insulin-like growth factor (IGF)-I and -II and the IGF-I and -II receptor genes during postnatal development of the rat ovary.
Levy MJ; Hernandez ER; Adashi EY; Stillman RJ; Roberts CT; LeRoith D
Endocrinology; 1992 Sep; 131(3):1202-6. PubMed ID: 1324154
[TBL] [Abstract][Full Text] [Related]
20. Serum factors alter the extent of dephosphorylation of ligands endocytosed via the mannose 6-phosphate/insulin-like growth factor II receptor.
Einstein R; Gabel CA
J Cell Biol; 1989 Sep; 109(3):1037-46. PubMed ID: 2549075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
